What is Cuvposa, and what is it used for?
Cuvposa is a prescription medicine whose active ingredient is glycopyrrolate. It is used to treat chronic drooling (excess saliva) in children that is caused by a neurologic condition such as cerebral palsy. [1][2]
How does Cuvposa work?
Glycopyrrolate is an anticholinergic medicine. It helps reduce saliva production by blocking certain signals in the body that increase drool. [1][2]
What forms does it come in, and how is it taken?
Cuvposa is taken by mouth, typically as an oral solution. The exact dosing schedule depends on the patient’s age and response, and it should be prescribed and adjusted by a clinician. [1][2]
What side effects are people most concerned about?
Because Cuvposa reduces some body secretions and affects nerve signaling, common side effects can include dry mouth and constipation, along with other anticholinergic-type effects. Serious side effects are possible with anticholinergic drugs, so patients and caregivers should follow the prescriber’s instructions closely. [1][2]
Who should be cautious or ask a doctor before using it?
Cuvposa may be risky for some people, especially those with certain gastrointestinal problems, urinary retention issues, or conditions where anticholinergic effects could cause complications. It can also be affected by the patient’s overall medical history and other medications, so clinicians typically screen for contraindications and interactions. [1][2]
Is it the same as Robinul or other glycopyrrolate products?
Cuvposa specifically refers to a glycopyrrolate product approved for the drooling indication in children. Other brands and formulations of glycopyrrolate can exist, but they are not automatically interchangeable for every patient or use—switching should be done only under clinician guidance. [1][2]
Sources:
[1] https://www.cuvposa.com/ (Cuvposa official site; product and indication information)
[2] https://www.drugs.com/cuvposa.html (Cuvposa glycopyrrolate prescribing/overview information)